<DOC>
	<DOCNO>NCT02307435</DOCNO>
	<brief_summary>Mesenchymal stem cell ( MSC ) one kind stem cell gain form adult tissue . Although MSC derive autogenic bone marrow proven help regeneration non union fracture long bone defect , aspiration process iliac crest invasive painful . Therefore , alternative source MSC less invasive need . Adipose umbilical cord `` waste product '' proven contain enormous MSC . Furthermore adipose umbilical cord allogenic source abundant number compare autogenic bone marrow . This enormous source need adequate preservation technique apply patient . According , researcher want explore potency MSC bone marrow , umbilical cord adipose source allogenic MSC effect cryopreservation technique viability quality MSC . We also compare effectivity MSC implantation bone marrow , umbilical cord adipose apply non union fracture long bone defect . Samples bone marrow , umbilical cord adipose cultured viability cell observe . Some cell implant directly patient non union fracture long bone defect cryopreserved liquid nitrogen -190 degree Celsius three month . All sample thaw viability cell observe . Patient implant MSC allogenic undergo clinical radiological examination third , sixth twenty second month implantation .</brief_summary>
	<brief_title>Allogenic Mesenchymal Stem Cell Bone Defect Non Union Fracture</brief_title>
	<detailed_description>Research Methods Study Design This study experimental one arm study post test . Estimated Study Time Research estimate time would 24 month , May 2014 May 2016 . Sample Gaining Procedure This research pilot study . Samples obtain consecutively source population meet criterion . The number sample mesenchymal stem cell ( adipose , bone marrow umbilical cord ) source three . Each sample derive three different donor meet inclusion criterion . For implanation , subject five intervention . Yet regard limited funding source time , recruit one subject kind MSC . Subject Criteria Inclusion criterion MSC donor Bone marrow donor : Male/female age 19-30 year without comorbiditites ( Diabetes mellitus , cardiovascular autoimmune disease ) , HIV test Hepatitis B test Hepatitis C test negaitve , fungal bacterial contamination bone marrow . Subjects willing aspiratied iliac crest order get bone marrow . Adipose donor : Adipose tissue gain liposuction open reduction internal fixation procedure . Samples adipose free HIV , Hepatitis B , Hepatitis C free fungal bacterial contamination . Umbilical cord donor : Umbilical cord form elective seccio caecaria fullterm mother without complication free HIV , hepatitis B , hepatitis C fungal bacterial contamination . Recipient inclusion criterion Critical bone defect patient age 6-55 willing undergo surgical intervention . Recipient exclusion criterion Patients pathological fracture cause malignancy , immunocompromised ( HIV AIDS , Diabetes mellitus , active Hepatitis ) , immunosuppresant therapy ( chemotherapy steroid ) . Drop criteria Patients rule study he/she state time research hold she/he undergoes threatment relate study . Patient show clinical improvement three consecutive month categorize fail threat . All drop fail threat patient could get threatment . Informed Consent All subject must fill sign inform consent letter . Research Protocol Mesenchymal stem cell take method Bone Marrow take Patient lie supine position , anesthetize locally . Aseptic antiseptic do illiac crest location . Aspiration needle insert 450 horizon illiac crest . Hub release 10 cc syringe contain heparin connect te needle . We aspirate 50 cc bone marrow subject . Umbilical cord take Right deliver baby , umbilical cord cut keep sterile bowl contain 0.9 % NaCl 40 sample proceed . Adipose take Adipose tissue derive liposuction open reduction internal fixation procedure . It keep sterile bowl contain NaCL 0.9 % 40 C. Processing sample do within 8 hour sample take . Cryopreservation activation . All sample take culture laboratory integrate service stem cell medical technology Cipto mangunkusumo hospita.this laboratory GMP ( good manufacturing Product ) certify . The sample eat culture appropriated medium reach confluence harvest . The cell undergo caracterisation test flow cyto meter viability number count . Some cell cryopreserved directly implant patient . The cell cryopreserved three month reactivate . Viability number measure . The cell implant non union patient . Specimen sterility Sterility test do three time ensure fungal bacterial contamination . HA-CaSO4 MSC For every centimeter defect , 10 million cell 50 pellet HA-CaSO4 need . The diluted MSC mix HA-CaSO4 incubate 5 minute implant . Intervention Surgical intervention need assemble fixation device long bone . During surgery , pellet HA-CaSO4 inserted defect . After soft tissue close rest serum inject defect area . Observation follow Clinical radiological follow do every 4 week . Observation do 12 month untill bone unites . Every subject follow third , sixth , twelfth twenty forth fixation device take . Recipient criterion non union fracture</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Fractures , Ununited</mesh_term>
	<mesh_term>Fibroma</mesh_term>
	<criteria>Inclusion criterion MSC donor Bone marrow donor : Male/female age 1930 year without comorbiditites ( Diabetes mellitus , cardiovascular autoimmune disease ) , HIV test Hepatitis B test Hepatitis C test negaitve , fungal bacterial contamination bone marrow . Subjects willing aspiratied iliac crest order get bone marrow . Adipose donor : Adipose tissue gain liposuction open reduction internal fixation procedure . Samples adipose free HIV , Hepatitis B , Hepatitis C free fungal bacterial contamination . Umbilical cord donor : Umbilical cord form elective seccio caecaria fullterm mother without complication free HIV , hepatitis B , hepatitis C fungal bacterial contamination . exclusion / Drop criteria Patients rule study he/she state time research hold she/he undergoes threatment relate study . Patient show clinical improvement three consecutive month categorize fail threat . All drop fail threat patient could get threatment . inclusion criterion recipient : male/female age 655 year old bone critical defect exclusion criterion recipient : Patients pathological fracture cause malignancy , immunocompromised ( HIV AIDS , Diabetes mellitus , active Hepatitis ) , immunosuppresant therapy ( chemotherapy steroid ) .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>non union fracture</keyword>
	<keyword>bone defect</keyword>
	<keyword>mesenchymal stem cell</keyword>
	<keyword>cryopreservation</keyword>
</DOC>